Bayesian Capital Management LP Buys 1,200 Shares of athenahealth (ATHN)
Bayesian Capital Management LP raised its stake in shares of athenahealth (NASDAQ:ATHN) by 21.2% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 6,855 shares of the health services provider’s stock after purchasing an additional 1,200 shares during the quarter. Bayesian Capital Management LP’s holdings in athenahealth were worth $980,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in ATHN. Schwab Charles Investment Management Inc. boosted its holdings in athenahealth by 8.1% during the fourth quarter. Schwab Charles Investment Management Inc. now owns 198,917 shares of the health services provider’s stock valued at $26,464,000 after purchasing an additional 14,933 shares in the last quarter. Teacher Retirement System of Texas boosted its holdings in athenahealth by 310.9% during the fourth quarter. Teacher Retirement System of Texas now owns 13,538 shares of the health services provider’s stock valued at $1,801,000 after purchasing an additional 10,243 shares in the last quarter. California Public Employees Retirement System boosted its holdings in athenahealth by 3.2% during the fourth quarter. California Public Employees Retirement System now owns 77,400 shares of the health services provider’s stock valued at $10,297,000 after purchasing an additional 2,400 shares in the last quarter. Daiwa Securities Group Inc. acquired a new stake in athenahealth during the fourth quarter valued at approximately $7,389,000. Finally, Swiss National Bank boosted its holdings in athenahealth by 2.0% during the fourth quarter. Swiss National Bank now owns 67,930 shares of the health services provider’s stock valued at $9,037,000 after purchasing an additional 1,300 shares in the last quarter.
Shares of athenahealth opened at $158.49 on Tuesday, according to Marketbeat.com. The company has a market capitalization of $6.40 billion, a PE ratio of 100.95, a price-to-earnings-growth ratio of 2.96 and a beta of 1.26. The company has a debt-to-equity ratio of 0.25, a quick ratio of 2.71 and a current ratio of 2.71. athenahealth has a one year low of $111.61 and a one year high of $163.94.
In related news, SVP Jonathan D. Porter sold 422 shares of the business’s stock in a transaction that occurred on Monday, May 7th. The shares were sold at an average price of $153.30, for a total value of $64,692.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Jonathan Bush sold 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 1st. The stock was sold at an average price of $124.01, for a total transaction of $620,050.00. Following the completion of the transaction, the chief executive officer now owns 340,106 shares of the company’s stock, valued at approximately $42,176,545.06. The disclosure for this sale can be found here. Insiders sold a total of 41,979 shares of company stock valued at $6,244,631 in the last 90 days. 2.90% of the stock is currently owned by corporate insiders.
ATHN has been the topic of a number of recent research reports. Royal Bank of Canada set a $141.00 price objective on athenahealth and gave the company a “hold” rating in a report on Thursday, February 15th. Piper Jaffray Companies reaffirmed a “buy” rating and set a $160.00 price objective on shares of athenahealth in a report on Friday, February 16th. BidaskClub raised athenahealth from a “strong sell” rating to a “sell” rating in a report on Saturday, February 17th. Bank of America initiated coverage on athenahealth in a report on Tuesday, February 27th. They set a “neutral” rating and a $147.00 price objective on the stock. Finally, JPMorgan Chase & Co. initiated coverage on athenahealth in a report on Tuesday, April 24th. They issued a “neutral” rating and a $159.00 target price on the stock. One research analyst has rated the stock with a sell rating, eighteen have assigned a hold rating and eight have given a buy rating to the stock. The stock has an average rating of “Hold” and an average price target of $154.86.
athenahealth, Inc, together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems. It offers athenaCollector, a network-enabled billing and practice management solution; athenaClinicals, an electronic health record for managing patient's clinical documentation; athenaCommunicator, an engagement and communication solution that provides an automated communication service between patients and provider practices for interactions outside the exam room; and athenaCoordinator for order transmission and care coordination services.
Want to see what other hedge funds are holding ATHN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for athenahealth (NASDAQ:ATHN).
Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.